Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin Alfa in Traumatic Brain Injury
IRCT201204149462N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of epoetin alfa in traumatic brain injury (TBI), sponsored by Tehran University of Medical Sciences. Started May 2009; status: completed.
02
Drugs
epoetin alfa
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT201204149462N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201204149462N1.